PubMed:33073202
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 100-108 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 449-457 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 41-42 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T2 | 140-143 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T3 | 308-309 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 28-39 | Chemical | denotes | Doxycycline | http://purl.obolibrary.org/obo/CHEBI_50845 |
T2 | 338-343 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 355-365 | Chemical | denotes | ivermectin | http://purl.obolibrary.org/obo/CHEBI_6078 |
T4 | 367-377 | Chemical | denotes | famotidine | http://purl.obolibrary.org/obo/CHEBI_4975 |
T5 | 383-394 | Chemical | denotes | doxycycline | http://purl.obolibrary.org/obo/CHEBI_50845|http://purl.obolibrary.org/obo/CHEBI_60648 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 0-10 | Chemical | denotes | Ivermectin | MESH:D007559 |
5 | 12-22 | Chemical | denotes | Famotidine | MESH:D015738 |
6 | 28-39 | Chemical | denotes | Doxycycline | MESH:D004318 |
7 | 100-108 | Disease | denotes | COVID-19 | MESH:C000657245 |
12 | 355-365 | Chemical | denotes | ivermectin | MESH:D007559 |
13 | 367-377 | Chemical | denotes | famotidine | MESH:D015738 |
14 | 383-394 | Chemical | denotes | doxycycline | MESH:D004318 |
15 | 449-457 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-40 | Sentence | denotes | Ivermectin, Famotidine, and Doxycycline: |
T2 | 41-109 | Sentence | denotes | A Suggested Combinatorial Therapeutic for the Treatment of COVID-19. |
T3 | 110-172 | Sentence | denotes | At times, combination therapy has proven to be very effective. |
T4 | 173-458 | Sentence | denotes | While no cure is available to date, herein we put forward with rationale and supporting evidence that if administrated simultaneously, a combination of FDA-approved drugs comprising ivermectin, famotidine, and doxycycline may provide robust chemoprophylaxis effective against COVID-19. |